Sung Lee
Director; EVP, Chief Financial Officer · 4 filings · Latest: May 5, 2026
CYTOKINETICS INC
Tango Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
CYTK | Sung Lee | EVP, Chief Financial Officer | May 5, 2026 | Sale | $76.87 | 23,906 | $1.8M | 63,221 | |
TNGX | Sung Lee | Director | Apr 29, 2026 | Grant/Award | $0.00 | 12,300 | — | 22,300 | |
CYTK | Sung Lee | EVP, Chief Financial Officer | Mar 17, 2026 | Sale | $62.15 | 4,935 | $306.7K | 87,127 | |
CYTK | Sung Lee | EVP, Chief Financial Officer | Mar 15, 2026 | Grant/Award | $0.00 | 20,646 | — | 92,062 |